Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6760)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2014 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhou YF, Xu W, Wang X, Sun JS, Xiang JJ, Li ZS, Zhang XF. Negative methylation status of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i36/13172.htm |
| Number | Citing Articles |
| 1 |
Reetta Holmila, Athena Sklias, David C. Muller, Davide Degli Esposti, Paule Guilloreau, James Mckay, Suleeporn Sangrajrang, Petcharin Srivatanakul, Pierre Hainaut, Philippe Merle, Zdenko Herceg, Andre Nogueira da Costa, John Luk. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma. PLOS ONE 2017; 12(3): e0174265 doi: 10.1371/journal.pone.0174265
|
| 2 |
F. I. Dwedar, G. I. Khalil, S. A. Nayer, A. Farouk. Aberrant Vimentin Methylation Is Characteristic of Breast Cancer. Advances in Breast Cancer Research 2016; 5(04): 150 doi: 10.4236/abcr.2016.54018
|
| 3 |
Constantin Pixberg, Wolfgang Schulz, Nikolas Stoecklein, Rui Neves. Characterization of DNA Methylation in Circulating Tumor Cells. Genes 2015; 6(4): 1053 doi: 10.3390/genes6041053
|
| 4 |
Margaret L. Thomas, Krysta M. Coyle, Mohammad Sultan, Paola Marcato. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. 2015; : 477 doi: 10.1007/978-3-319-21030-8_17
|
| 5 |
David E. Amacher. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 2016; 21(5): 387 doi: 10.3109/1354750X.2016.1153724
|
| 6 |
Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Martin Berg Johansen, Inge Søkilde Pedersen, Henrik Krarup, Ole Thorlacius-Ussing. Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. Oncotarget 2017; 8(55): 93942 doi: 10.18632/oncotarget.21397
|
| 7 |
Mai-Britt Worm Ørntoft. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?. Clinical Colorectal Cancer 2018; 17(2): e415 doi: 10.1016/j.clcc.2018.02.012
|
| 8 |
José Gabriel Rodríguez TARAZONA, Emne Ali ABDALLAH, Bianca de Cássia Troncarelli FLORES, Alexcia Camila BRAUN, Cláudia Malheiros Coutinho CAMILLO, Fabio Albuquerque MARCHI, Anna Paula Carreta RUANO, Ludmilla Thome Domingos CHINEN. PROTEÍNAS MIR-203A-3P E MMP-2 SÃO ALTAMENTE EXPRESSAS EM CÉLULAS TUMORAIS CIRCULANTES DE PACIENTES COM CARCINOMA PANCREÁTICO. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2021; 34(4) doi: 10.1590/0102-672020210002e1628
|
| 9 |
Nidhi Singh, Sumaira Rashid, Safoora Rashid, Nihar Ranjan Dash, Surabhi Gupta, Anoop Saraya. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients. Journal of Cancer Research and Clinical Oncology 2020; 146(4): 897 doi: 10.1007/s00432-020-03169-y
|